If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

Share Price Information for Apax Global Alpha (APAX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 151.60
Bid: 150.20
Ask: 153.00
Change: 0.00 (0.00%)
Spread: 2.80 (1.864%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 151.60
APAX Live PriceLast checked at -
Apax Global Alpha is an Investment Trust

To provide shareholders with capital appreciation from our investment portfolio and regular dividends.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

2020 Final Results

2 Mar 2021 07:00

RNS Number : 7821Q
Apax Global Alpha Limited
02 March 2021
 

(LSE: APAX)

 

 

 

Apax Global Alpha Limited

Annual results for the period ended 31 December 2020

 

 

Key highlights

 

· Strong full year performance delivered a Total NAV Return1 of 14.8% (21.6% constant currency) despite a challenging Covid-19 backdrop

 

· Benefitted from sector-driven strategy and portfolio weighting towards Tech and Digital (47% of invested portfolio) which proved more resilient against the impact of Covid-19.

 

· Private Equity portfolio was the key driver of strong full year results, achieving 25.4% Total Return1, and AGA received distributions of €207.3m during the period. The average uplift on Private Equity exits was 40%2 to previous Unaffected Valuations2.

 

· Continued to invest in attractive opportunities with nine new Private Equity investments in Apax X and the Apax Digital Fund, primarily in technology.

 

· Robust performance of Derived Debt portfolio impacted by currency headwinds (0.2% Total Return, 7.4% constant currency Total Return).

 

· Healthy liquidity position with €93.5m of available cash3 and an unused revolving credit facility of €140.0m, and which post-period end was converted to an evergreen structure4. Derived Investments of €319.4m provide a further source of capital flexibility.

 

· Dividend of 5.28p per share declared for the full year 2020, in line with AGA's stated dividend policy of distributing 5% of NAV per annum.

 

 

Tim Breedon CBE, Chairman of Apax Global Alpha, said:

 

"While progress in developing and deploying a range of vaccines against Covid-19 is encouraging, the outlook remains uncertain. Five years post IPO, AGA's portfolio is now mature with Private Equity generating substantial cash distributions and the portfolio diversified across funds at all stages of the investment cycle. Against the current market backdrop, the resilience of the portfolio and AGA's sector-driven strategy means the Company should continue to provide long-term value generation opportunities and attractive income for shareholders. "

 

Commenting on the results, Ralf Gruss, COO of Apax Partners, said:

 

"AGA performed strongly in 2020, delivering double-digit total NAV returns for investors. The strength of the business model can be seen through several successful realisations with good uplifts as well as attractive new investments despite the challenging market conditions. The focus on global opportunities across four key sectors means AGA's portfolio continues to be well positioned for emerging opportunities as we come out of the crisis."

 

 

Financial highlights

 

· Adjusted NAV5 grew to €1.20 billion, up from €1.09 billion in 2019.

 

· Portfolio weighted towards Private Equity (71%) vs. Derived Investments (29%), and resilient sectors such as Tech and Digital (47%), Services (26%) and Healthcare (18%).

 

· AGA was 93% invested. As at 31 December 2020 the Company had outstanding commitments to the Apax Funds (together with recallable distributions) of €458.8m (38% of NAV). In addition to future Private Equity distributions, funding sources that can be accessed for future Private Equity calls include Derived Investments of €319.4m, an undrawn revolving credit facility of €140.0m, available cash3 of €93.5m.

 

FY 2020

FY 2020

FY 2019

FY 2019

Adjusted NAV4

EUR 1,201m

GBP 1,074m

EUR 1,092m

GBP 924m

Adjusted NAV4 per share

EUR 2.45

GBP 2.19

EUR 2.22

GBP 1.88

NAV4 per share

EUR 2.45

GBP 2.19

EUR 2.24

GBP 1.89

 

Exposure

FY 2020

FY 2020constant currency

Total NAV Return1

14.8%

21.6%

Total Return1 - Private Equity

66%

25.4%

32.6%

Total Return1 - Derived Debt

23%

0.2%

7.4%

Total Return1 - Derived Equity

4%

(3.8%)

2.5%

Cash & Others

7%

 

 

 

Private Equity portfolio highlights

 

· The Private Equity portfolio performed strongly, delivering Total Return of 25.4% (32.6% constant currency) in the year.

 

· Exit activity was reflective of Apax Partners' investment strategy and sub-sector expertise (including in software, tech-enabled services, online marketplaces, and specialty pharmaceuticals) with average uplifts to Unaffected Valuations2 of 40% achieved on exits. This is testament to the business transformation achieved under the Apax Funds' ownership.

 

· Aggregate Gross IRR6 and Gross MOIC6 on Private Equity exits7 and IPO's in FY 2020 were 45.0% and 4.1x respectively.

 

· On a look-through basis, AGA invested c.€69.4m in nine new investments during the year, primarily in Tech.

 

· Continued strong operating performance from the portfolio companies: Revenue and EBITDA growth of 6.6% and 20.8% respectively across the Private Equity portfolio.

 

 

Derived Investments portfolio highlights

 

· Derived Investments leverage the insights and expertise of Apax Partners. The portfolio is weighted towards Tech and Digital and is predominantly invested in Derived Debt (86% of Derived Investments).

 

· The Derived Investment portfolio was adversely impacted by the weakness of the US Dollar. On a constant currency basis, the portfolio was up 6.5%, translating to a Total Return of (0.6)% in euro terms.

 

· AGA deployed €87.4m in ten new investments in Derived Debt during the year, reflecting AGA's strategy to invest capital as it becomes available following exits in the Private Equity portfolio. There were no new investments in Derived Equity.

 

· Aggregate Gross IRR8 and Gross MOIC8 on Derived Debt realisations were 12.2% and 1.2x respectively whilst Derived Equity realisations generated an aggregate Gross IRR8 and Gross MOIC8 of 25.5% and 1.7x

 

For further information regarding the announcement of AGA's 2020 Annual Results, including the annual report and Company's results presentation and details for today's analyst and investor webcast at 9.30am (UK time), please visit www.apaxglobalalpha.com.

 

Contact details

Katarina Sallerfors

Investor Relations - AGA

 

Telephone: +44 (0)207 666 6526

 

Email: katarina.sallerfors@apax.com

 

 

 

 

APPENDIX

 

Movements in NAV

 

Adjusted NAV5 movements (€m)

Private Equity

Derived Investments

Cash

 

Treasury Shares

Facility drawn

Other9

 

Total

Adjusted NAV at 31.12.19

759.4

342.2

3.3

-

-

(12.8)

1,092.1

+ Investments

55.7

87.4

(124.8)

-

-

(18.3)

-

- Distributions/ divestments

(207.3)

(90.0)

296.7

-

-

0.6

-

+ Interest and dividend income

-

-

18.8

-

-

(0.4)

18.4

+/- Gains/(losses)

225.1

1.4

-

-

-

-

226.8

+/- FX gains/(losses)10

(51.5)

(21.9)

(2.4)

-

-

-

(75.8)

+/- Costs and other movements

-

-

(7.2)

-

-

(0.2)

(7.4)

 - Dividends paid

-

-

(52.9)

-

-

-

(52.9)

+/- Performance fee reserve11

6.9

-

-

(6.9)

-

-

-

+/- Shares purchased

-

-

(6.9)

6.9

-

-

-

+/- Revolving credit facility

drawn/repaid

-

-

-

-

-

-

-

Adjusted NAV at 31.12.20

788.3

319.4

124.6

-

-

(31.1)

1,201.2

 

Private Equity - operational metrics

 

Private Equity - operational metrics

31 December 2020

31 December 2019

Portfolio year-over-year LTM revenue growth12

6.6%

20.9%

Portfolio year-over-year LTM EBITDA growth12

20.8%

15.9%

Enterprise Value / EBITDA valuation multiple12

16.9x*

17.2x

Net debt / EBITDA multiple12

3.9x*

3.7x

 

*Excluding Cole Haan which faced significant challenges throughout the year due to lockdown measures and distorts the numbers. Including Cole Haan, the weighted average valuation multiple was 22.4x and portfolio net debt was 5.2x LTM EBITDA.

 

Derived Investments - operational metrics

 

Derived Investments - operational metrics

31 December 2020

31 December 2019

Debt year-over-year LTM EBITDA growth13

26.2%

14.6%

Debt average income yield to maturity13

8.1%

9.3%

Debt average years to maturity

5.7

6.0

Debt average income yield14

7.3%

8.8%

Equity price-to-earnings ratio15

7.1x

20.7x

 

 

Other Invested Portfolio highlights

 

Invested Portfolio analysis16

€m

€m

%

%

Private Equity

788.3

71%

- AMI

25.1

2%

- AEVI

5.3

0%

- AEVII

29.2

3%

- AVIII

180.7

16%

- AIX

500.7

45%

- ADF

34.3

3%

- AX

13.0

1%

Derived Investments

319.4

29%

- Derived Debt

275.7

25%

- Derived Equity

43.7

4%

Total

1,107.7

100%

 

 

 

 

 

Footnotes

1.

"Total NAV Return" means the movement in the Adjusted NAV per share over the quarter plus any dividends paid. "Total Return" reflects the sub-portfolio performance on a stand-alone basis. It excludes items at the overall AGA level such as cash, management fees, and costs

2.

Valuation uplifts on exits are calculated based on the total actual or estimated sales proceeds and income as appropriate since the last Unaffected Valuation. Unaffected Valuation is determined as the fair value in the last quarter before exit, when valuation is not affected by the exit process (i.e. because an exit was signed, or an exit was sufficiently close to being signed that the Apax Funds incorporated the expected exit multiple into the quarter end valuation). Average uplift of partial exits and IPO's includes proceeds received and the closing fair value at 31 December 2020

3.

Available cash consists of €124.6m of cash less net current liabilities of €31.1m

4.

Either party is required to give 2 years notice to terminate the agreement

5.

Adjusted NAV and NAV were the same at €1,201.2m as the performance fee reserve was nil at year end

6.

Private Equity Aggregate Gross IRR and Gross MOIC calculated based on the expected aggregate cash flows in euro across all funds for the deals signed and IPO'd in the year. Gross IRR represents concurrent Gross IRR.

7.

The Apax funds made seven full exits, three significant partial exits and two IPOs.

8.

Derived Debt and Equity Gross MOIC and Gross IRR calculated based on aggregate concurrent euro cash flows since inception for deals fully exited during the year.

9.

Other reflects net current liabilities at 31 December 2020 of which €31.0m due was related to debt investments that were purchased but had yet to settle at year end.

10.

FX on cash includes the revaluation of cash balances and net losses arising from the differences in exchange rates between transaction dates and settlement dates, and unrealised net losses arising from the translation into euro of assets and liabilities (other than investments) which are not denominated in euro

11.

Movement in the Private Equity performance fee reserve of €6.9m reflects the settlement of the performance fee reserve by the Company's purchase of shares in the market and subsequent issuance of those shares to the Investment Manager for performance fee accrued in the prior year. This does not represent the underlying Private Equity portfolio's carried interest. There was no performance fee accrued during FY 2020.

12.

Gross Asset Value weighted average of the respective metric across the portfolio. LTM Revenue growth and LTM EBITDA growth rates exclude companies where EBITDA is not meaningful such as financial services or high growth business with fluctuations in EBITDA. Huayue Education and TietoEVRY are also excluded due to the unavailability of reported data. Net debt/EBITDA multiple and EV/EBITDA valuation multiple excluded companies where EBITDA is not meaningful such as financial services or high growth business valued on a revenue basis. MATCHESFASHION.COM is excluded due to low EBITDA from opex investments and short-term fluctuations in EBITDA. Cole Haan has been excluded at December 2020 with the Net Debt/EBITDA and EV/EBITDA multiples as 5.2x and 22.4x respectively when included.

13.

Gross Asset Value weighted average of the respective metric across the Derived Debt portfolio. (No exclusions)

14.

Gross Asset Value weighted average of the current full year income (annual coupon/clean price as at the respective date) for each debt position in the Derived Debt portfolio as at the respective date

15

Gross Asset Value weighted average of the respective metric across the Derived Equity portfolio (Answers, FullBeauty, Just Group and Cengage were excluded from LTM earnings growth and Answers, FullBeauty and Cengage were excluded from P/E ratio)

16

Invested Portfolio excludes cash and cash equivalents, revolving credit facility drawn and net current assets, including these the NAV is €1,201.2m and Adjusted NAV was the same as there was no performance fee reserve at 31 December 2020

 

Notes

 

1.

Note that references in this announcement to Apax Global Alpha Limited have been abbreviated to "AGA" or "the Company". References to Apax Partners LLP have been abbreviated to "Apax Partners" or "the Investment Adviser"

 

2.

Please be advised that this announcement may contain inside information as stipulated under the Market Abuse Regulations (EU) NO. 596/2014 ("MAR")

 

3.

This announcement is not for release, publication or distribution, directly or indirectly, in whole or in part, into or within the United States or to "US persons" (as defined in Regulation S under the United States Securities Act of 1933, as amended (the "Securities Act")) or into or within Australia, Canada, South Africa or Japan. Recipients of this announcement in jurisdictions outside the UK should inform themselves about and observe any applicable legal requirements in their jurisdictions. In particular, the distribution of the announcement may be restricted by law in certain jurisdictions

 

4.

The information presented herein is not an offer for sale within the United States of any equity shares or other securities of Apax Global Alpha Limited ("AGA"). AGA has not been and will not be registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act"). In addition, AGA's shares (the "Shares") have not been and will not be registered under the Securities Act or any other applicable law of the United States. Consequently, the Shares may not be offered or sold or otherwise transferred within the United States, or to, or for the account or benefit of, US Persons, except pursuant to an exemption from the registration requirements of the Securities Act and under circumstances which will not require AGA to register under the Investment Company Act. No public offering of the Shares is being made in the United States

 

5.

This announcement may include forward-looking statements. The words "expect", "anticipate", "intends", "plan", "estimate", "aim", "forecast", "project" and similar expressions (or their negative) identify certain of these forward-looking statements. These forward-looking statements are statements regarding AGA's intentions, beliefs or current expectations concerning, among other things, AGA's results of operations, financial condition, liquidity, prospects, growth and strategies. The forward-looking statements in this presentation are based on numerous assumptions regarding AGA's present and future business strategies and the environment in which AGA will operate in the future. Forward-looking statements involve inherent known and unknown risks, uncertainties and contingencies because they relate to events and depend on circumstances that may or may not occur in the future and may cause the actual results, performance or achievements of AGA to be materially different from those expressed or implied by such forward looking statements. Many of these risks and uncertainties relate to factors that are beyond AGA's ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behaviour of other market participants, the actions of regulators and other factors such as AGA's ability to continue to obtain financing to meet its liquidity needs, changes in the political, social and regulatory framework in which AGA operates or in economic or technological trends or conditions. Past performance should not be taken as an indication or guarantee of future results, and no representation or warranty, express or implied, is made regarding future performance. AGA expressly disclaims any obligation or undertaking to release any updates or revisions to these forward-looking statements to reflect any change in AGA's expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based after the date of this announcement, or to update or to keep current any other information contained in this announcement. Accordingly, undue reliance should not be placed on the forward-looking statements, which speak only as of the date of this announcement.

 

About Apax Global Alpha Limited

 

AGA is a Guernsey registered closed-ended collective investment scheme incorporated as a non-cellular company that listed on the London Stock Exchange on 15 June 2015. It is regulated by the Guernsey Financial Services Commission.

 

AGA's objective is to provide shareholders with capital appreciation from its investment portfolio and regular dividends. The Company is targeting an annualised Total Return, across economic cycles, of 12-15% (net of fees and expenses) including a dividend yield of 5% of Net Asset Value.

 

The investment policy of the Company is to make Private Equity investments in Apax Funds, and Derived Investments which are investments in equities and debt derived from the insights gained via Apax Partners' Private Equity activities.

 

Further information regarding the Company and its publications are available on the Company's website at www.apaxglobalalpha.com.

 

About Apax Partners LLP

 

Apax Partners LLP ("Apax Partners") is a leading global private equity advisory firm and over its nearly 50-year history, Apax Partners has raised and advised funds with aggregate commitments of more than €60 billion. Funds advised by Apax Partners invest in companies across four global sectors of Tech, Services, Healthcare and Consumer. These funds provide longterm equity financing to build and strengthen worldclass companies.

 

For further information about Apax Partners, please visit www.apax.com. Apax Partners is authorised and regulated by the Financial Conduct Authority in the UK.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FR UPUPPWUPGPPG
Date   Source Headline
17th Aug 20177:00 amRNS2017 Interim Results Highlights
1st Aug 20177:00 amRNSApax Funds' Valuations as at 30 June 2017
14th Jul 201710:51 amRNSDirectors' Dealings - Sarah Evans
12th Jul 201710:00 amRNSDirectors' Dealings - Chris Ambler
5th Jul 20177:00 amRNSUpdate: Second Release from Lock-up
4th Jul 20173:09 pmRNSPDMR Dealing - Martin Halusa
15th Jun 20177:00 amRNSNotification of Interim Results
24th May 20177:00 amRNSAGA Investor Day
24th May 20177:00 amRNSSecond Release from Lock-up
24th May 20177:00 amRNSAGA's commitment to Apax Digital Fund
18th May 20175:24 pmRNSPDMR Dealing - Nico Hansen
25th Apr 20177:00 amRNSQ1 2017 Results Highlights
18th Apr 20173:35 pmRNSResult of Second AGM
31st Mar 20174:11 pmRNSPDMR Dealing - Martin Halusa
31st Mar 20174:11 pmRNSPDMR Dealing - Ralf Gruss Options
31st Mar 20174:01 pmRNSHolding(s) in Company
23rd Mar 20177:00 amRNSNotification of Investor Day
20th Mar 20177:00 amRNSQ1 2017 Financial Highlights
17th Mar 201710:00 amRNSPDMR Dealing - Apax Holdco Transfers
17th Mar 201710:00 amRNSPDMR Dealing - Share Transfers
17th Mar 201710:00 amRNSPDMR Dealing - Andrew Sillitoe
7th Mar 20177:00 amRNSNotice of Second Annual General Meeting
7th Mar 20177:00 amRNS2016 Annual Dividend Announcement
7th Mar 20177:00 amRNS2016 Annual Report and Accounts
7th Mar 20177:00 amRNS2016 Final Results
31st Jan 20177:00 amRNSApax Funds' Valuations as at 31 December 2016
16th Jan 20177:00 amRNSNotification of 2016 Annual Results
18th Nov 201611:42 amRNSSenior Independent Director Appointment
1st Nov 20167:00 amRNSQ3 2016 Results Highlights
25th Oct 20167:00 amRNSApax Funds' Valuations as at 30 September 2016
27th Sep 20167:00 amRNSNotification of Quarterly Results
17th Aug 20167:00 amRNS2016 Interim Dividend
17th Aug 20167:00 amRNS2016 Interim Report and Accounts
17th Aug 20167:00 amRNS2016 Interim Financial Highlights
26th Jul 20167:00 amRNSNotification of Interim Results
25th Jul 20162:26 pmRNSApax Funds' Valuations as at 30 June 2016
22nd Jul 20161:48 pmRNSDirector Declaration - Additional Directorship
5th Jul 201612:23 pmRNSDirectorate Changes (Correction)
5th Jul 201611:11 amRNSDirector Dealings
4th Jul 20164:56 pmRNSSecondary Placing of Ordinary Shares
1st Jul 20164:11 pmRNSDirectorate Changes
14th Jun 20161:11 pmRNSOrdinary Shares Lock up Release 1st Tranche
27th Apr 20167:00 amRNSQ1 2016 Financial Highlights
11th Apr 20167:00 amRNSResults of First AGM 8 April 2016
5th Apr 20167:00 amRNSNotification of Investor Day
30th Mar 20169:52 amRNSElectronic Communications
29th Mar 20167:00 amRNSNotification of Quarterly Results
21st Mar 201611:34 amRNSWeb Voting and Investor Portal Facility
18th Mar 201610:43 amRNSCirc re. Electronic Communications
8th Mar 20167:00 amRNSNotice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.